Lead candidate Telomir-1 reverses aging markers, restores muscle mass, and boosts survival in genetic progeria model Telomir Pharmaceuticals (TELO), a ...
Telomir Pharmaceuticals (TELO) has caught the attention of institutional investors, with JPMorgan Chase & Co. (JPM) significantly increasing its position ...
Stabilizing Silver(II) for Enhanced Antimicrobial and Wound Healing Applications Telomir Pharmaceuticals (TELO) has announced a groundbreaking scientific achievement—its proprietary compound, ...
Innovative drug shows potential to address aging, chronic diseases, and avian influenza through oxidative stress reversal Telomir Pharmaceuticals (TELO), a ...
Novel Therapy Shows Promise in Restoring Lifespan and Addressing Accelerated Aging Telomir Pharmaceuticals (TELO), a leader in age-reversal science, has ...
Emerging Findings Position Telomir-1 as a Promising Solution for Copper Metabolism Disorders and Expand Its Potential Applications Telomir Pharmaceuticals (TELO), ...
